Since our founding in 2007, Akebia (Nasdaq: AKBA) has been focused on achieving better outcomes for people with kidney disease. We are a leader in the renal community – a fully integrated biopharmaceutical company with capabilities ranging from research through commercialization.
We have a portfolio focused on addressing significant unmet needs for people living with kidney disease.
RESEARCH & DEVELOPMENT
Events & Presentations
January 11, 2022 at 4:30 PM EST
January 10, 2022 at 7:00 AM EST
Nov 30 - December 2, 2021